Home » Module 1 » References

References

1 Tory Dent, Black Milk. (Sheep’s Meadow Press, 2005).
2 F Pulido, JR Arribas, JM Miro et al., J Acquir Immune Defic Syndr. 35 (4), 343
(2004).
3 A Patel, K Patel, J Patel et al., J Acquir Immune Defic Syndr. 37 (1), 1166 (2004).
4 M Mascolini, Making Right Turns in the HIV Pharmacology Maze, Available at
http://www.thebody.com/iapac/jul04/pharmacology.html, (July 2004).
5 H Ribaudo, D Clifford, and R Gulick, presented at the 11th Conference on
Retroviruses and Opportunistic Infections, San Francisco, February 8-11, 2004
(unpublished); DrugSafetySite: Efavirnez, Available at
http://www.drugsafetysite.com/efavirenz.
6 C V Fletcher, Navigating the Concentration Curves: Pharmacologic
Considerations in the Treatment of HIV, Available at
http://doctor.medscape.com/viewprogram/4562, (2005).
7 Where did HIV come from?, Available at
http://www.cdc.gov/hiv/resources/qa/qa3.htm, (OCt 20 2006).
8 F Gao, E Bailes, DL Robertson et al., Nature 397, 436 (1999).
9 A Kannabus, S Allen, and B Boer, The Origin of HIV & The First Cases of AIDS,
Available at http://www.avert.org/origins.htm, (Oct 23 2006).
10 A Chitnis, D Rawls, and J Moore, AIDS Research and Human Retroviruses 16
(1), 5 (2000).
11 T Barnett and A Whiteside, AIDS in the Twenty-First Century. (Palgrave
MacMillan, New York, 2002).
12 A Kanabus, S Allen, and B Boer, The Origin of HIV & The First Cases of AIDS,
Available at http://www.avert.org/origins.htm, (Oct 23 2006).
13 P Blancou, JP Vartanian, C Christopherson et al., Nature 410, 1045 (2001); N
Berry, C Davis, A Jenkins et al., Nature 410, 1046 (2001).
14 I W Sherman, The Power of Plagues. (ASM Press, Washington DC, 2006).
15 Randy Shilts, And The Band Played On: Politics, People, and the AIDS Epidemic.
(Saint Martin’s Press, New York, 1987).
16 TA Peterman, HW Jaffe, PM Feorino et al., JAMA 254 (20), 2913 (1985).
17 Ryan White, Available at http://www.ryanwhite.com.
18 S Kleinman, MP Busch, JJ Korelitz et al., Transfus Med Rev. 11, 155 (1997).
19 SA Glynn, SH Kleinman, GB Schreiber et al., JAMA 284 (2), 229 (2000).
20 AE Ling, KE Robbins, TM Brown et al., JAMA 284 (2), 210 (2000).
21 D Serwadda, R D Mugerwa, and N K Sewankambo, Lancet 2, 849 (1985).
22 I. Weller, D H Crawford, V. Iliescu et al., Annals of the New York Academy of
Science 437, 248 (1984); N Clumeck and J Sonnet, NEJM 310 (8), 492 (1984).
23 G Behrman, The Invisible People. (Free Press, New York, 2004).
24 A. C. Bayley, Lancet 1, 1318 (1984); R Coker and P B Wood, Trans R Soc Trop
Med Hyg 80 (6), 965 (1986).
25 P Van de Perre, D Rouvroy, and P Lepage, Lancet 2, 65 (1984); P Piot, T. C.
Quinn, and H Taelman, Lancet 2, 65 (1984).
26 Karen Stanecki, 1986.
27 Department of Health, 2010. National Antenatal Sentinel HIV and Syphilis
Prevalence Survey in South Africa, 2009.
28 P Lyman, 2002; .
29 A Goldis, in USA Today (Los Angeles (AP), 2001).
30 MTV Real World: Real World Reviews, Available at
http://brianx.com/br2cmtvrealworld.html.
31 D Vaillancourt, in The Peak (Burnaby, 1994).
32 Pedro Zamora, Available at http://www.aidsaction.org/pedro.htm.
33 Judd Winick, Pedro and Me: Friendship, Loss, and What I Learned. (Henry Holt
& Co., 2000).
34 K Shillinger, in The Boston Globe (Boston, Oct 12, 1999).
35 Stop AIDS Project. HIV, AIDS, STD: Definitions, Available at
http://www.stopaids.org/resources/std_info/definitions.html.
36 Tina Rosenberg, in The New York Times (New York City, 2004).
37 National Cancer Institute: Dictionary of Cancer Terms, Available at
http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=256572.
38 Lee Reichmann and Janice Tanne, Timebomb: The Global Epidemic of Multi-
Drug Resistant Tuberculosis. (McGraw Hill, New York, 2002).
39 A J Cann, Principles of Molecular Virology, Chapter 4, 2nd ed. (Academic Press,
1997).
40 Bamford, Research in Microbiology 154, 231 (2003).
41 E Rybicki, Introduction to Molecular Virology: What is a Virus?, Available at
http://www.mcb.uct.ac.za/tutorial/virwhat.html, (1998).
42 George Rice, Microbial Life Educational Resources: Are Viruses Alive?,
Available at http://serc.carleton.edu/microbelife/yellowstone/viruslive.html.
43 National Institute of Allergy and Infectious Disease: How HIV Causes AIDS,
Available at http://www.niaid.nih.gov/factsheets/howhiv.htm.
44 Microbiology and Immunology On-Line, University of South Carolina School of
Medicine. Bacteriology: Chapter Seven, Bacteriophages, Available at
http://pathmicro.med.sc.edu/mayer/phage.htm.
45 R Gallo, F Wong-Stall, L Montagnier et al., Nature 333 (6173), 504 (1988); M A
Muesing, D H Smith, C D Cabradilla et al., Nature 313 (6002), 450 (1985).
46 B C Hare, Clinical Overview of HIV Disease, Available at
http://hivinsite.ucsf.edu/InSite?page=kb-03-01-01, (2006).
47 National Institute of Allergy and Infectious Disease. HIV Infection and AIDS: An
Overview, Available at http://www.niaid.nih.gov/factsheets/hivinf.htm.
48 A Kanabus and Rob Noble, Preventing Mother-To-Child Transmission of HIV,
Available at http://www.avert.org/motherchild.htm, (Jan 11 2007); R Denison,
WORLD (October 2001).
49 Infections Associated with HIV, Available at
http://hivinsite.ucsf.edu/InSite?page=kb-05.
50 L Gooze, Bacteria Infections Associated with HIV, Available at
http://hivinsite.ucsf.edu/InSite?page= kb-05-01-01#S9X, (Apr 1998).
51 J A Aberg and W G Powderly, Cryptococcosis and HIV. May 2006. , Available at
http://hivinsite.ucsf.edu/InSite?page=kb-05&doc=kb-05-02-05 (May 2006).
52 C W Lerner and M L Tapper, Medicine (Baltimore) 63 (3), 155 (1984).
53 R G Miller, J R Storey, and C M Greco, Neurology 40 (4), 569 (1990); W L Drew
and J P Lalezari, Cytomegalovirus and HIV, Available at
http://hivinsite.ucsf.edu/InSite?page=kb-05-03-03#S1X, (May 2006).
54 J G Montoya and J S Remington, Toxoplasma gondii. In: Mandell GL, Bennett
JE, Dolin R, eds. Principles and Practice of Infectious Diseases. (Churchilll
Livingstone, Philadelphia, 2000).
55 B J Luft and J S Remington, Clin Infect Dis 15 (2), 211 (1992).
56 B A Navia, C K Petito, J W Gold et al., Ann Neurol 19 (3), 224 (1986).
57 C S Subauste, Toxoplasmosis and HIV, Available at
http://hivinsite.ucsf.edu/InSite?page=kb-05&doc=kb-05-04-03, (Mar 2006).
58 American Cancer Society Detailed Guide: Kaposi’s Sarcoma., Available at
http://www.cancer.org/docroot/cri/content/cri_2_4_1x_what_is_kaposis_sarcoma
_21.asp?sitearea=cri, (Mar 2006).
59 San Francisco AIDS Foundation: HIV Testing, Available at
http://www.sfaf.org/aids101/hiv_testing.html, (Aug 30, 2005).
60 R P Johnson and S Kalams, The Science of HIV Vaccine Development, Available
at http://hivinsite.ucsf.edu/InSite?page=kb-02-01-06#S5X, (May 1998).
61 S C Piscitelli, Antiretroviral Pharmacology: Issues and Management, Available at
http://www.thebody.com/sfaf/winter00/pharmacology.html, (Winter 2000).
62 Zidovudine (Retrovir, AZT), Available at http://www.thebody.com/nmai/azt.html,
(2006).
63 Q J Sattentau, Curr Opin Immunol 8 (4), 540 (196).
64 E L Cooney, A C Collier, P D Greenberg et al., Lancet 337 (8741), 567 (1991).
65 B K Chakrabarti, R K Maitra, X Z Ma et al., Proc Natl Acad Sci U S A 93 (18),
9810 (1996); M D Daniel, F Kirchhoff, S C Czajak et al., Science 258 (5090),
1938 (1992).
66 Stanford University: HIV Drug Resistance Database, Available at
http://hivdb.stanford.edu/pages/documentPage/primer.html, (Sept 1999).
67 D L Robertson, B H Hahn, and P M. Sharp, J Mol Evol 40 (3), 249 (1995).
68 D L Robertson, P M Sharp, F E McCutchan et al., Nature 374 (6518), 124 (1995).
69 J M Coffin, Curr Top Microbiol Immunol 176, 143 (1992); D S Burke, Emerging
Infectious Diseases 3 (3) (1997).
70 W S Hu and H M Termin, Proc Natl Acad Sci USA 87, 1556 (1990).
71 Jon Cohen, Science 287 (5455), 942 (2000).
72 Jon Cohen, Science 288 (5474), 2165 (2000).
73 Jon Cohen, Science 305 (5690), 1545 (2004).
74 UNAIDS. 2010. Global report: UNAIDS report on the global AIDS epidemic
2010. UNAIDS: Geneva, Switzerland. Accessed online [8/30/2011]:
http://www.unaids.org/documents/20101123_GlobalReport_em.pdf.
75 V Brittain, in The Guardian (Tuesday, March 14 2000).
76 UNAIDS. 2006. Global report: UNAIDS report on the global AIDS epidemic,
May 2006
77 Barton Gellman, in Washington Post (July 5, 2000).
78 R L Swarns, in The New York Times (New York, Aug 22 2000).
79 P Sidely, BMJ 322, 447 (2001).
80 Medact and WDM. (1999). Deadly conditions? Examining the relationship
between debt relief policies and HIV/AIDs. World Development
Movement, London. September 1999
81 in The Guardian (Saturday December 2, 2000).
82 Centers for Disease Control and Prevention. HIV Surveillance Report, 2008; vol.
20. Published June 2010. Accessed [Aug.2011].
83 CDC, 2006.
84 Nexus (2004).
85 Fact Sheet: Continuing the Fight Against HIV/AIDS in America, Available at
http://www.whitehouse.gov/news/releases/2006/02/20060201-10.html, (Feb
2006).
86 Wide-Ranging Set of HIV/AIDS Bills to be Considered in California’s 2006
Legislative Session, Available at http://www.sfaf.org/policy/pw/2006_3.html#3,
(Mar 2006).
87 Peter H. Duesberg: Homepage at the University of California, Berkeley
Department of Biochemistry and Molecular Biology, Available at
http://mcb.berkeley.edu/faculty/BMB/duesbergp.html.
88 P Duesberg, Science 241, 514 (1988).